日期 影响因子
日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:
–

Pharmacogenetic Profiling of Cytochrome P450 Enzymes in Plasmodium vivax Patients Treated with Chloroquine and Primaquine: Implications for Personalized Malaria Therapy

对接受氯喹和伯氨喹治疗的间日疟原虫患者进行细胞色素P450酶的药物遗传学分析：对个体化疟疾治疗的启示

期刊:American Journal of Tropical Medicine and Hygiene
影响因子:1.6
doi:10.4269/ajtmh.25-0612
Phompradit, Papichaya; Muhamad, Phunuch; Cheoymang, Anurak; Na-Bangchang, Kesara
微生物学
细胞生物学
疟疾
发表日期：2026
文献求助 收藏

Bioassay for total serum bioactivity of Atractylodes lancea

白术总血清生物活性的生物测定

期刊:Journal of Advanced Pharmaceutical Technology & Research
影响因子:
doi:10.4103/japtr.japtr_431_22
Na-Bangchang, Kesara; Cheoymang, Anurak; Muhamad, Nadda; Kulma, Inthuon
发表日期：2023
文献求助 收藏

Association between ABCB1 Polymorphisms and Artesunate-Mefloquine Treatment Responses of Patients with Falciparum Malaria on the Thailand-Myanmar Border

泰国-缅甸边境地区恶性疟疾患者ABCB1多态性与青蒿琥酯-甲氟喹治疗反应的相关性

期刊:American Journal of Tropical Medicine and Hygiene
影响因子:1.6
doi:10.4269/ajtmh.21-0047
Boonprasert, Kanyarat; Kosa, Nanthawat; Muhamad, Poonuch; Cheoymang, Anurak; Na-Bangchang, Kesara
微生物学
疟疾
ABCB1
发表日期：2021
文献求助 收藏

Preliminary investigation of the contribution of CYP2A6, CYP2B6, and UGT1A9 polymorphisms on artesunate-mefloquine treatment response in Burmese patients with Plasmodium falciparum malaria

初步研究CYP2A6、CYP2B6和UGT1A9多态性对缅甸恶性疟患者青蒿琥酯-甲氟喹治疗反应的影响

期刊:American Journal of Tropical Medicine and Hygiene
影响因子:1.6
doi:10.4269/ajtmh.13-0531
Phompradit, Papichaya; Muhamad, Poonuch; Cheoymang, Anurak; Na-Bangchang, Kesara
发表日期：2014
文献求助 收藏